135 related articles for article (PubMed ID: 26566916)
1. Treatment of SPG5 with cholesterol-lowering drugs.
Mignarri A; Malandrini A; Del Puppo M; Magni A; Monti L; Ginanneschi F; Tessa A; Santorelli FM; Federico A; Dotti MT
J Neurol; 2015 Dec; 262(12):2783-5. PubMed ID: 26566916
[No Abstract] [Full Text] [Related]
2. SPG5 siblings with different phenotypes showing reduction of 27-hydroxycholesterol after simvastatin-ezetimibe treatment.
Mignarri A; Carecchio M; Del Puppo M; Magistrelli L; Di Bella D; Monti L; Dotti MT
J Neurol Sci; 2017 Dec; 383():39-41. PubMed ID: 29246618
[No Abstract] [Full Text] [Related]
3. Hereditary spastic paraplegia type 5: a potentially treatable disorder of cholesterol metabolism.
Mignarri A; Malandrini A; Del Puppo M; Magni A; Monti L; Ginanneschi F; Tessa A; Santorelli FM; Federico A; Dotti MT
J Neurol; 2014 Mar; 261(3):617-9. PubMed ID: 24509641
[No Abstract] [Full Text] [Related]
4. Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5.
Marelli C; Lamari F; Rainteau D; Lafourcade A; Banneau G; Humbert L; Monin ML; Petit E; Debs R; Castelnovo G; Ollagnon E; Lavie J; Pilliod J; Coupry I; Babin PJ; Guissart C; Benyounes I; Ullmann U; Lesca G; Thauvin-Robinet C; Labauge P; Odent S; Ewenczyk C; Wolf C; Stevanin G; Hajage D; Durr A; Goizet C; Mochel F
Brain; 2018 Jan; 141(1):72-84. PubMed ID: 29228183
[TBL] [Abstract][Full Text] [Related]
5. Vascular and metabolic effects of ezetimibe combined with simvastatin in patients with hypercholesterolemia.
Koh KK; Oh PC; Sakuma I; Kim EY; Lee Y; Hayashi T; Han SH; Park YM; Shin EK
Int J Cardiol; 2015 Nov; 199():126-31. PubMed ID: 26188833
[TBL] [Abstract][Full Text] [Related]
6. Effects of ezetimibe/simvastatin combination on metabolic parameters.
Filippatos TD; Elisaf MS
Int J Cardiol; 2016 Jan; 202():273-4. PubMed ID: 26408840
[No Abstract] [Full Text] [Related]
7. Ezetimibe-Simvastatin, a pharmacodynamic interaction?
Lozano R; Marin R; Santacruz MJ; Freire I
Expert Opin Pharmacother; 2013 Feb; 14(3):359-60. PubMed ID: 23346887
[No Abstract] [Full Text] [Related]
8. The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers.
Efrati S; Averbukh M; Dishy V; Faygenzo M; Friedensohn L; Golik A
Eur J Clin Pharmacol; 2007 Feb; 63(2):113-21. PubMed ID: 17200833
[TBL] [Abstract][Full Text] [Related]
9. The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia.
Florentin M; Liberopoulos EN; Moutzouri E; Rizos CV; Tselepis AD; Elisaf MS
Curr Med Res Opin; 2011 Mar; 27(3):685-92. PubMed ID: 21271793
[TBL] [Abstract][Full Text] [Related]
10. Reply to comment on: Effects of ezetimibe/simvastatin combination on metabolic parameters by Prof. Moses S Elisaf.
Koh KK; Oh PC; Sakuma I
Int J Cardiol; 2016 Jan; 202():154-5. PubMed ID: 26397402
[No Abstract] [Full Text] [Related]
11. Simvastatin but not ezetimibe reduces sympathetic activity despite similar reductions in cholesterol levels.
Lewandowski J; Siński M; Puchalska L; Symonides B; Gaciong Z
J Am Soc Hypertens; 2014 Oct; 8(10):715-23. PubMed ID: 25418493
[TBL] [Abstract][Full Text] [Related]
12. Endothelial Effect of Statin Therapy at a High Dose Versus Low Dose Associated with Ezetimibe.
Garcia MM; Varela CG; Silva PF; Lima PR; Góes PM; Rodrigues MG; Silva Mde L; Ladeia AM; Guimarães AC; Correia LC
Arq Bras Cardiol; 2016 Apr; 106(4):279-88. PubMed ID: 27142792
[TBL] [Abstract][Full Text] [Related]
13. Increasing doses of simvastatin versus combined ezetimibe/simvastatin: effect on circulating endothelial progenitor cells.
Pesaro AE; Serrano CV; Katz M; Marti L; Fernandes JL; Parra PR; Campos AH
J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):447-52. PubMed ID: 23739650
[TBL] [Abstract][Full Text] [Related]
14. Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis.
Schüle R; Siddique T; Deng HX; Yang Y; Donkervoort S; Hansson M; Madrid RE; Siddique N; Schöls L; Björkhem I
J Lipid Res; 2010 Apr; 51(4):819-23. PubMed ID: 19812052
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans.
Landmesser U; Bahlmann F; Mueller M; Spiekermann S; Kirchhoff N; Schulz S; Manes C; Fischer D; de Groot K; Fliser D; Fauler G; März W; Drexler H
Circulation; 2005 May; 111(18):2356-63. PubMed ID: 15867181
[TBL] [Abstract][Full Text] [Related]
16. Elevated hydroxycholesterols in Norwegian patients with hereditary spastic paraplegia SPG5.
Prestsæter S; Koht J; Lamari F; Tallaksen CME; Hoven STJ; Vigeland MD; Selmer KK; Rydning SL
J Neurol Sci; 2020 Dec; 419():117211. PubMed ID: 33160247
[TBL] [Abstract][Full Text] [Related]
17. [Does ezetimibe combined with simvastatin increase the risk of renal failure].
Fernández-Liz E; Ortí Segarra C; Garrido Mesas I
Aten Primaria; 2014 Oct; 46(8):451-2. PubMed ID: 24837405
[No Abstract] [Full Text] [Related]
18. [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].
Lancellotti P; Pierard LA; Scheen AJ
Rev Med Liege; 2015 Sep; 70(9):450-5. PubMed ID: 26638446
[TBL] [Abstract][Full Text] [Related]
19. The effect of ezetimibe and simvastatin on monocyte cytokine release in patients with isolated hypercholesterolemia.
Krysiak R; Okopien B
J Cardiovasc Pharmacol; 2011 Apr; 57(4):505-12. PubMed ID: 21297492
[TBL] [Abstract][Full Text] [Related]
20. The effect of short-term combined treatment with simvastatin and ezetimibe on circulating adipokine levels in patients with isolated hypercholesterolemia.
Krysiak R; Zmuda W; Marek B; Okopień B
Endokrynol Pol; 2014; 65(4):275-80. PubMed ID: 25185849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
